secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2024-11-01T23:59:59+00:00
Accession:  0001104659-24-113486
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

TriSalus: Director Anil Singhal resigns; CMO Steven Katz departs
----------------------------------------------------------------

- Director Anil Singhal resigned from Board, Compensation and Science/Technology committees effective Oct 28, 2024; no disagreement.
- Chief Medical Officer Steven Katz left employment effective Oct 29, 2024.
- No replacements announced for either role, creating two leadership vacancies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000110465924113486/0001104659-24-113486-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000110465924113486/tm2427190d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-113486

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer